COMMUNIQUÉS West-GlobeNewswire
-
Proteostasis Therapeutics Prices Public Offering of Common Stock
14/12/2017 - 02:31 -
argenx raises approximately $231 million in gross proceeds in an upsized U.S. public offering
14/12/2017 - 01:27 -
Telix Pharmaceuticals and Memorial Sloan Kettering Cancer Center Announce Renal Cancer Collaboration
13/12/2017 - 23:30 -
DiaMedica Therapeutics Announces Non-Brokered Private Placement
13/12/2017 - 22:48 -
Nabriva Therapeutics Added to NASDAQ Biotechnology Index
13/12/2017 - 22:05 -
Flexion Therapeutics Announces Acquisition of Novel, Non-Opioid Asset for Osteoarthritis of the Knee
13/12/2017 - 22:05 -
ExactCare Pharmacy Welcomes Terry Rogers as Chief Growth Officer
13/12/2017 - 22:00 -
ContraVir Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until December 21, 2017
13/12/2017 - 22:00 -
AveXis Announces Plan to Initiate Phase 1 Trial in SMA Type 2 Utilizing Intrathecal Delivery of AVXS-101
13/12/2017 - 22:00 -
Emerald Health Announces No Material Change
13/12/2017 - 21:00 -
RedHawk Initiates Plan to Eliminate Debt
13/12/2017 - 21:00 -
Tivity Health and Linkwell Health Recognized for Efforts to Engage Seniors through Digital Platform
13/12/2017 - 20:30 -
CohBar Announces Approval for Listing on the NASDAQ Capital Market
13/12/2017 - 18:53 -
Tauriga Sciences, Inc. Fully Repays $80,000 USD 5% Face Value Convertible Debenture Issued to GS Capital Partners, LLC on June 27, 2017 for One Time Cash Payment of $108,164.38 USD
13/12/2017 - 18:51 -
Tyme to Present at Biotech Showcase™ 2018
13/12/2017 - 18:00 -
CyberFuels Inc. announces distribution expansion throughout Canada and the USA
13/12/2017 - 17:15 -
Solera Health Expands Its Board of Directors with the Addition of Healthcare Industry Leader Mary Langowski
13/12/2017 - 16:00 -
Ossur Hf : Financial calendar 2018
13/12/2017 - 15:41 -
Allakos Secures $100 Million In Series B Financing
13/12/2017 - 15:00
Pages